Ainos (AIMD) investor relations material

Ainos Q2 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Q2 2025 earnings summary13 Aug, 2025

Executive summary

  • Transitioned from R&D to commercial deployment of AI Nose, securing a $2.1M multi-year order and launching SmellTech-as-a-Service, with pilot deployments in industrial, robotics, and senior care sectors in Asia.

  • Expanded strategic partnerships in robotics, semiconductors, and automation, with AI Nose achieving up to 90% accuracy in food/beverage scent classification and 85% in eldercare hygiene detection.

  • Advanced VELDONA clinical trials in Taiwan for rare, autoimmune, and veterinary diseases, with promising interim results.

  • Ceased COVID-19 test kit sales to focus on AI-powered scent digitization and VOC sensing products.

Financial highlights

  • Q2 2025 revenue was $4,663, up from nil in Q2 2024; H1 2025 revenue reached $110,870, up 435% year-over-year, mainly from VOC sensing and AI Nose product sales.

  • Q2 2025 net loss was $4,084,990, a 28% increase year-over-year; H1 2025 net loss was $7,371,012, up 13%.

  • Gross margin improved to $3,726 in Q2 2025 from a $25,373 loss in Q2 2024; H1 2025 gross profit was $91,700 versus a $31,398 loss in H1 2024.

  • Operating expenses rose 24% in Q2 2025 and 14% in H1 2025, mainly due to higher share-based compensation.

  • Cash and cash equivalents were $1,223,184 as of June 30, 2025, down from $3,892,919 at year-end 2024.

Outlook and guidance

  • 90-day roadmap targets completion of 1,400 AI Nose pilot deployments and expansion to 5,000 units, with potential scale-up to 15,000 units.

  • Anticipates increased clinical trial spending for VOC POCT and VELDONA programs and higher R&D investment.

  • Expects cash reserves, business revenues, and potential debt financing to fund operations for the next twelve months, but may need to raise additional capital.

  • Management notes substantial doubt about ability to continue as a going concern without additional funding.

  • Focus on expanding SmellTech-as-a-Service subscription model and pursuing strategic partnerships in Asia and Europe.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Ainos earnings date

Q3 20254 Nov, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Ainos earnings date

Q3 20254 Nov, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Ainos Inc. is a healthcare technology company focused on the development of medical diagnostic solutions and therapeutics. The company specializes in point-of-care testing devices and therapeutic innovations based on its proprietary technologies. Ainos’ product offerings include rapid diagnostic tests for infectious diseases and other health conditions, aiming to provide efficient and accessible healthcare solutions. The company also explores advancements in other areas, such as AI-driven diagnostics and anti-inflammatory treatments. The company is headquartered in San Diego, California, and its shares are listed on the Nasdaq.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage